These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

671 related items for PubMed ID: 7678816

  • 1. Effects of combined administration of interleukin-6 and granulocyte colony-stimulating factor on recovery from radiation-induced hemopoietic aplasia.
    Patchen ML, Fischer R, MacVittie TJ.
    Exp Hematol; 1993 Feb; 21(2):338-44. PubMed ID: 7678816
    [Abstract] [Full Text] [Related]

  • 2. Mast cell growth factor enhances multilineage hematopoietic recovery in vivo following radiation-induced aplasia.
    Patchen ML, Fischer R, Schmauder-Chock EA, Williams DE.
    Exp Hematol; 1994 Jan; 22(1):31-9. PubMed ID: 7506673
    [Abstract] [Full Text] [Related]

  • 3. Effects of recombinant granulocyte colony-stimulating factor (rG-CSF) and recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) on acute radiation hematopoietic injury in mice.
    Tanikawa S, Nakao I, Tsuneoka K, Nara N.
    Exp Hematol; 1989 Sep; 17(8):883-8. PubMed ID: 2475360
    [Abstract] [Full Text] [Related]

  • 4. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 5. Mast cell growth factor (C-kit ligand) in combination with granulocyte-macrophage colony-stimulating factor and interleukin-3: in vivo hemopoietic effects in irradiated mice compared to in vitro effects.
    Patchen ML, Fischer R, MacVittie TJ, Seiler FR, Williams DE.
    Biotherapy; 1993 Dec; 7(1):13-26. PubMed ID: 7520725
    [Abstract] [Full Text] [Related]

  • 6. The combined effects of interleukin-11, stem cell factor, and granulocyte colony-stimulating factor on newborn rat hematopoiesis: significant enhancement of the absolute neutrophil count.
    Cairo MS, Plunkett JM, Schendel P, van de Ven C.
    Exp Hematol; 1994 Oct; 22(11):1118-23. PubMed ID: 7523164
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic administration of recombinant human granulocyte colony-stimulating factor accelerates hemopoietic regeneration and enhances survival in a murine model of radiation-induced myelosuppression.
    Patchen ML, MacVittie TJ, Solberg BD, Souza LM.
    Int J Cell Cloning; 1990 Mar; 8(2):107-22. PubMed ID: 1690250
    [Abstract] [Full Text] [Related]

  • 8. Survival enhancement and hemopoietic regeneration following radiation exposure: therapeutic approach using glucan and granulocyte colony-stimulating factor.
    Patchen ML, MacVittie TJ, Solberg BD, Souza LM.
    Exp Hematol; 1990 Oct; 18(9):1042-8. PubMed ID: 1697806
    [Abstract] [Full Text] [Related]

  • 9. In vivo and in vitro interaction between interleukin 6 and granulocyte colony-stimulating factor in the regulation of murine hematopoiesis.
    Pojda Z, Tanaka K, Aoki Y, Tsuboi A.
    Exp Hematol; 1992 Aug; 20(7):874-8. PubMed ID: 1378408
    [Abstract] [Full Text] [Related]

  • 10. Granulocyte colony-stimulating factor and amifostine (Ethyol) synergize to enhance hemopoietic reconstitution and increase survival in irradiated animals.
    Patchen ML, MacVittie TJ.
    Semin Oncol; 1994 Oct; 21(5 Suppl 11):26-32. PubMed ID: 7526469
    [Abstract] [Full Text] [Related]

  • 11. Effect of in vivo administration of IL-3 and IL-6, alone and in combination with G-CSF, GM-CSF or IL-1, on haematopoiesis, graft-versus-host disease and survival after murine haematopoietic stem cell transplantation.
    Atkinson K, Vos B, Kang-Er Z, Guiffre A, Seymour R, Gillis S.
    Cytokines Mol Ther; 1995 Mar; 1(1):47-55. PubMed ID: 9384663
    [Abstract] [Full Text] [Related]

  • 12. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K, Inoue S, Kumar A.
    Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
    [Abstract] [Full Text] [Related]

  • 13. A synergistic increase in transplantable peripheral blood stem cells in mice by co-administration of recombinant human interleukin 6 and recombinant human granulocyte colony-stimulating factor.
    Suzuki H, Okano A, Suzuki C, Konishi A, Akiyama Y, Ishibashi T, Ozawa K, Asano S.
    Transplantation; 1995 Jun 15; 59(11):1596-600. PubMed ID: 7539959
    [Abstract] [Full Text] [Related]

  • 14. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
    Palmeri S, Leonardi V, Danova M, Porta C, Ferrari S, Fincato G, Citarrella P.
    Haematologica; 1999 Nov 15; 84(11):1016-23. PubMed ID: 10553163
    [Abstract] [Full Text] [Related]

  • 15. alpha-Galactosylceramide (AGL-517) treatment protects mice from lethal irradiation.
    Inoue H, Koezuka Y, Nishi N, Osawa M, Motoki K, Kobayashi E, Kabaya K, Obuchi M, Fukushima H, Mori KJ.
    Exp Hematol; 1997 Aug 15; 25(9):935-44. PubMed ID: 9257806
    [Abstract] [Full Text] [Related]

  • 16. Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice.
    Drize N, Chertkov J, Samoilina N, Zander A.
    Exp Hematol; 1996 Jun 15; 24(7):816-22. PubMed ID: 8647232
    [Abstract] [Full Text] [Related]

  • 17. Improved survival of lethally irradiated recipient mice transplanted with circulating progenitor cells mobilized by IL-8 after pretreatment with stem cell factor.
    Laterveer L, Zijlmans JM, Lindley IJ, Hamilton MS, Willemze R, Fibbe WE.
    Exp Hematol; 1996 Oct 15; 24(12):1387-93. PubMed ID: 8913284
    [Abstract] [Full Text] [Related]

  • 18. Interleukin 1-induced sequential myelorestoration: dynamic relation between granulopoiesis and progenitor cell recovery in myelosuppressed mice.
    Ido M, Harada M, Furuichi H, Matsuoka N, Nakano K, Sohmura Y.
    Exp Hematol; 1992 Feb 15; 20(2):161-6. PubMed ID: 1371964
    [Abstract] [Full Text] [Related]

  • 19. Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation-induced marrow aplasia.
    Farese AM, Hunt P, Grab LB, MacVittie TJ.
    J Clin Invest; 1996 May 01; 97(9):2145-51. PubMed ID: 8621805
    [Abstract] [Full Text] [Related]

  • 20. In vivo protective effects of tetrapeptide AcSDKP, with or without granulocyte colony-stimulation factor, on murine progenitor cells after sublethal irradiation.
    Watanabe T, Brown GS, Kelsey LS, Yan Y, Jackson JD, Ewel C, Kessinger A, Talmadge JE.
    Exp Hematol; 1996 May 01; 24(6):713-21. PubMed ID: 8635527
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.